Research location
Andernach
Germany
Advertisement
Research activity in Andernach
GermanyCureCurrent currently publishes aggregate city-level research activity for this location: 9 trials and 9 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Andernach
9 linked trials · page 1 of 1Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic SyndromeNCT03440736 · 2018-02-28 · 1 site observation
COMPLETED
Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to MonotherapyNCT01609153 · 2012-06-01 · 1 site observation
COMPLETED
STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START)NCT01585298 · 2012-04-29 · 1 site observation
COMPLETED
Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS)NCT01405820 · 2011-08-01 · 1 site observation
COMPLETED
Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe COPDNCT01285180 · 2010-08-01 · 1 site observation
COMPLETED
Effectiveness and Safety of Firmagon®NCT00930319 · 2009-06-01 · 1 site observation
COMPLETED
Tysabri Observational ProgramNCT00493298 · 2007-06-29 · 1 site observation
COMPLETED
Non-interventional Observational Study With Pramipexole: Impact on Non-motor Symptoms in Parkinson's DiseaseNCT00539214 · 2007-03-01 · 1 site observation
COMPLETED
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung CancerNCT00050960 · 2002-05-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.